Roche and Hansoh ink cancer drug deal potentially worth more than $14B
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Greenspace in the immediate surroundings of the home linked to lower dementia risk
Urban residents with more greenery within 100 meters (328 feet) of their homes have a 20% lower risk of developing dementia over time, according to a new study from Stockholm University and Karolinska…
Disparities in breast cancer mortality between rural and urban patients projected to widen by 2035
Between 1999 and 2020, breast cancer mortality declined across rural and urban populations, but by 2005, mortality among rural patients surpassed that of urban patients and after 2013 remained…
Disc’s once-spurned rare disease drug to get a second chance at approval
Months after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 trial and now plans to re-engage regulators.
Pharmacology Master’s Scholarships in Canada With CAD $25,000 Yearly Allowance
University of British Columbia (UBC) in Canada has opened applications for its Master of Science (MSc) in Pharmacology, offering a … Read More The post Pharmacology Master’s Scholarships in Canada…
'Constipation' Lands Patient in Surgery for Unusual Anatomy
(MedPage Today) -- In an "exceptionally" rare case, an infant with abdominal distention, vomiting, and constipation was found to have a second colon, researchers reported.
Doctors may be less likely to discuss screening options for colorectal cancer with newly eligible younger adults
Among surveyed U.S. adults aged 45–49, who are eligible for colorectal cancer (CRC) screening per the U.S. Preventive Services Task Force (USPSTF) recommendations, only about half reported that their…